Vaxcyte, Inc. (PCVX)

SEC filing

Vaxcyte, Inc.

PCVX · CIK 1649094

4 · Sep 2, 2026 · CHIEF OPERATING OFFICER Wassil Jim sold 3,477 shares at $61.07/share ($212.4K); exercised options for 4,500 shares; reported 2,705 shares

CHIEF OPERATING OFFICER Wassil Jim sold 3,477 shares at $61.07/share ($212.4K); exercised options for 4,500 shares; reported 2,705 shares

Filed: Sep 2, 2026
Period: Aug 31, 2026
Accession: 0001813798-26-000017
Filer: Vaxcyte, Inc.

View on SEC.gov All SEC filings

Filing document

FORM 4

xslF345X06/wk-form4_1788393516.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4FORM 4wk-form4_1788393516.xml
Open SEC.gov